This is the first time plasma UCH-L1 is studied in subarachnoid hemorrhage (aSAH).
Increased plasma UCH-L1 is associated with unfavorable neurological outcome in aSAH.
Repetitive measurements of UCH-L1 could be the optimal approach for clinical studies.